1. Home
  2. MDXH vs GMM Comparison

MDXH vs GMM Comparison

Compare MDXH & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • GMM
  • Stock Information
  • Founded
  • MDXH 2003
  • GMM 2017
  • Country
  • MDXH Belgium
  • GMM China
  • Employees
  • MDXH N/A
  • GMM N/A
  • Industry
  • MDXH
  • GMM
  • Sector
  • MDXH
  • GMM
  • Exchange
  • MDXH Nasdaq
  • GMM Nasdaq
  • Market Cap
  • MDXH 84.6M
  • GMM 70.8M
  • IPO Year
  • MDXH 2021
  • GMM 2023
  • Fundamental
  • Price
  • MDXH $2.30
  • GMM $2.54
  • Analyst Decision
  • MDXH Buy
  • GMM
  • Analyst Count
  • MDXH 1
  • GMM 0
  • Target Price
  • MDXH $6.00
  • GMM N/A
  • AVG Volume (30 Days)
  • MDXH 70.5K
  • GMM 14.3K
  • Earning Date
  • MDXH 08-20-2025
  • GMM 07-11-2025
  • Dividend Yield
  • MDXH N/A
  • GMM N/A
  • EPS Growth
  • MDXH N/A
  • GMM 62.17
  • EPS
  • MDXH N/A
  • GMM 6.37
  • Revenue
  • MDXH $94,507,000.00
  • GMM $41,360,953.00
  • Revenue This Year
  • MDXH $23.51
  • GMM N/A
  • Revenue Next Year
  • MDXH $17.68
  • GMM N/A
  • P/E Ratio
  • MDXH N/A
  • GMM $0.40
  • Revenue Growth
  • MDXH 25.46
  • GMM 53.82
  • 52 Week Low
  • MDXH $1.35
  • GMM $1.69
  • 52 Week High
  • MDXH $3.50
  • GMM $15.60
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 58.21
  • GMM 40.95
  • Support Level
  • MDXH $1.90
  • GMM $2.77
  • Resistance Level
  • MDXH $2.21
  • GMM $2.73
  • Average True Range (ATR)
  • MDXH 0.12
  • GMM 0.14
  • MACD
  • MDXH 0.00
  • GMM -0.04
  • Stochastic Oscillator
  • MDXH 82.35
  • GMM 14.40

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: